Disbrow Joshua R. 4
4 · AYTU BIOPHARMA, INC · Filed Oct 7, 2025
Insider Transaction Report
Form 4
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Award
Common Stock
2025-10-03+22,500→ 207,203 total - Award
Common Stock
2025-10-03+31,446→ 184,703 total
Footnotes (2)
- [F1]The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus.
- [F2]Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.